. Author manuscript; available in PMC: 2020 Jan 17.

Published in final edited form as: ACS Omega. 2019 Dec 24;5(1):822–831. doi: 10.1021/acsomega.9b03626

Table 1.

FP results for the primary hit compound 1 and a set of its commercially available analogues. All values represent the mean of three independent experiments ± standard deviation. ND=Not detectable.

Compound	Structure	% inhibition at 50 μM
1		65.8 ± 11.7
2		4.6 ± 2.2
3		39.4 ± 9.8
4		21.0 ± 5.0
5		ND